Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Exploring sex variations in the incidence of cardiovascular events: a counterfactual decomposition analysis

  • Castel-Feced, Sara
  • Malo, Sara
  • Aguilar-Palacio, Isabel
  • Maldonado, Lina
  • Rabanaque, María José
  • San Sebastián, Miguel
Background: Some cardiovascular risk factors (CVRFs) that occur differently in men and women can be addressed to reduce the risk of suffering a major adverse cardiovascular event (MACE). Furthermore, the development of MACE is highly influenced by social determinants of health. Counterfactual decomposition analysis is a new methodology that has the potential to be used to disentangle the role of different factors in health inequalities. This study aimed to assess sex differences in the incidence of MACE and to estimate how much of the difference could be attributed to the prevalence of diabetes, hypertension, hypercholesterolaemia and socioeconomic status (SES). Methods: Descriptive and counterfactual analyses were conducted in a population of 278 515 people with CVRFs. The contribution of the causal factors was estimated by comparing the observed risk ratio with the causal factor distribution that would have been observed if men had been set to have the same factor distribution as women. The study period was between 2018 and 2021. Results: The most prevalent CVRF was hypercholesterolaemia, which was similar in both sexes, while diabetes was more prevalent in men. The incidence of MACE was higher in men than in women. The main causal mediating factors that contributed to the sex differences were diabetes and SES, the latter with an offsetting effect. Conclusions: This result suggests that to reduce the MACE gap between sexes, diabetes prevention programmes targeting men and more gender-equal salary policies should be implemented.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Cohort Profile: The CArdiovascular Risk factors for hEalth Services research (CARhES) cohort study

  • Aguilar-Palacio, Isabel
  • Rabanaque, MªJosé
  • Castel, Sara
  • Maldonado, Lina
  • González-García, Juan
  • Compés, Luisa
  • Malo, Sara
Key Features The CARhES (CArdiovascular Risk factors for hEalth Services research) study is a population cohort that uses Real-World Data to study the impact of health services and drug utilization on health outcomes in patients with cardiovascular risk factors and to identify potential healthcare inequalities. The ultimate goal is to develop strategies that enhance the medical management of these patients by promoting effective and equitable care. This is a population dynamic open cohort that includes all people aged ≥16 years old registered as users of the Aragón public health system (Spain) with hypertension, diabetes mellitus and/or dyslipidaemia from 2017 (number of participants: 446 998). Follow-up will last at least until the end of 2026, with annual waves of data extraction. Data on socio-demographics, clinical conditions, medications and use of health services are collected from clinical and administrative electronic databases. Due to its sensitive nature, the CARhES cohort data are not publicly accessible. However, researchers who wish to perform specific analyses, explore new methodologies or conduct cross-national comparisons related to healthcare utilization in patients with cardiovascular risk factors are encouraged to contact the Principal Investigators of the study: Isabel Aguilar-Palacio (iaguilar@unizar.es) and Sara Malo (smalo@unizar.es).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Initiation of lipid-lowering therapy as primary prevention of cardiovascular disease in the elderly

  • Vinuesa-Hernando, José Manuel
  • Aguilar-Palacio, Isabel
  • Rabanaque, María José
  • García-Cárdenas, Victoria
  • Lallana, María Jesús
  • Gamba, Adriana
  • Malo, Sara
Aims This study aimed to analyse the initiation adherence phase to lipid-lowering therapy for primary prevention of cardiovascular disease in a Spanish population aged 70 years or older. The secondary objective was to identify the determinants of initiation and early discontinuation. Methods This was an observational study conducted in the CArdiovascular Risk factors for HEalth Service research (CARhES) cohort. People aged 70 and older with a first prescription of a lipid-lowering drug and without a previous major adverse cardiovascular event (MACE) were selected (2018–2021). Data on sociodemographics, clinical conditions, drugs and use of health services were collected from clinical and administrative electronic databases. The study population was classified into: non-initiation, early discontinuation (i.e., discontinuation after the first dispensing) and initiation with more than one dispensing. Their characteristics were compared. Determinants of initiation and early discontinuation were explored. Results Among the 15 019 people studied, 80.2% initiated the medication, 11.2% showed an early discontinuation and 8.6% were non-initiators. An older age or conditions such as dementia, diabetes or depression reduced the likelihood of initiation, while obesity and a high pharmacological burden increased it. People over 90 years of age or those prescribed a statin in combination were more likely to have an early discontinuation. Conclusions Non-initiation and early discontinuation are common among older people prescribed lipid-lowering drugs as primary prevention of cardiovascular disease for the first time. The presence of chronic pathologies other than cardiovascular ones should be considered when assessing whether or not to prescribe these drugs in the elderly.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Gender inequalities in secondary prevention of cardiovascular disease: a scoping review

  • López Ferreruela, Irene
  • Obón Azuara, Blanca
  • Malo Fumanal, Sara
  • Rabanaque Hernández, María José
  • Aguilar-Palacio, Isabel
Background Despite significant progress in cardiovascular disease (CVD) management, it remains a public health priority and a global challenge. Within the disease process, health care after a cardiovascular event (secondary prevention) is essential to prevent recurrences. Nonetheless, evidence has suggested the existence of gender disparities in CVD management, leaving women in a vulnerable situation. The objective of this study is to identify all available evidence on the existence of gender differences in health care attention after a major adverse cardiovascular event. Methods A scoping review following the structure of PRISMA-ScR was conducted. To define the inclusion criteria, we used Joanna Briggs Institute (JBI) population, concept, context framework for scoping reviews. A systematic search was performed in MEDLINE (PubMed), EMBASE and Cochrane. The methods of this review are registered in the International Platform of Registered Systematic Review and Meta-Analysis Protocols (INPLASY) (INPLASY202350084). Results The initial search retrieved 3,322 studies. 26 articles were identified manually. After the reviewing process, 93 articles were finally included. The main intervention studied was the pharmacological treatment received (n = 61, 66%), distantly followed by guideline-recommended care (n = 26, 28%) and cardiac rehabilitation (CR) referral (n = 16)”. Literature described gender differences in care and management of secondary prevention of CVD. Women were less frequently treated with guideline-recommended medications and seem more likely to be non-adherent. When analysing guideline recommendations, women were more likely to make dietary changes, however, men were more likely to increase physical activity. Studies also showed that women had lower rates of risk factor testing and cholesterol goals attainment. Female sex was associated with lower rates of cardiac rehabilitation referral and participation. Conclusions This review allowed us to compile knowledge on the existence of gender inequalities on the secondary prevention of CVD. Additional research is required to delve into various factors influencing therapeutic disparities, referral and non-participation in CR programs, among other aspects, in order to improve existing knowledge about the management and treatment of CVD in men and women. This approach is crucial to ensure the most equitable and effective attention to this issue.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Primary care utilisation in different patients’ profiles with cardiovascular risk factors

  • Malo, Sara
  • Maldonado, Lina
  • Rabanaque, María José
  • Bengoa-Urrengoechea, Irantzu
  • Castel-Feced, Sara
  • Sánchez-Calavera, María Antonia
  • Aguilar-Palacio, Isabel
Background This study aimed to identify profiles of patients with cardiovascular disease (CVD) risk factors, based on their sociodemographic and clinical characteristics, and to analyse how their complexity is related to their frequency of visits in Primary Care. Methods Observational longitudinal study conducted in the Spanish CArdiovascular Risk factors for HEalth Services research (CARhES) cohort. Individuals older than 15 with hypertension, type 2 diabetes mellitus (DM) and/or dyslipidaemia in 2017 were selected and followed until 2021. Cluster analyses were performed to identify patients’ profiles according to age, sex and morbidity burden. Characteristics and annual visits in Primary Care in the different profiles were described. Panel data models were applied to study the variability of the frequency of visits to both physicians and nurses in Primary Care in the profiles across different time points. Results In this population-based cohort of 446,998 individuals, different profiles were identified among those with hypertension, type 2 DM and/or dyslipidaemia. Profiles comprising the elderly showed the highest morbidity burden. Among the profiles of individuals under 80, those that included women had a higher burden than profiles with men. This higher complexity was associated with higher frequency of Primary Care visits, regardless of the patient’s socioeconomic level and depopulation level of his/her Basic Health Area. Conclusions Women and the elderly comprised the profiles with the highest morbidity burden and Primary Care attendance. Tailoring care and resources according to the complexity profile is essential to ensure that patients receive the best possible care based on their needs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Gender inequalities in prescribing and initiation patterns of guideline-recommended drugs after acute myocardial infarction

  • López-Ferreruela, Irene
  • Malo, Sara
  • Obón-Azuara, Blanca
  • Rabanaque, María José
  • Gamba, Adriana
  • Castel-Feced, Sara
  • Aguilar-Palacio, Isabel
Background European guidelines recommend the prescription of certain drugs after acute myocardial infarction (AMI). The existence of gender differences in pharmacological treatment after an AMI has been described. This study aims to describe and analyse, using real-world data (RWD), whether there are gender differences in the prescribing patterns and initiation of treatment in secondary prevention after a first AMI, and which are the factors that explain these differences. Methods A population-based observational study of RWD was conducted in the CARhES (CArdiovascular Risk factors for hEalth Services research) cohort. The study included subjects who had experienced a first episode of AMI between 2017 and 2022, had survived the event, and had a minimum follow-up of 180 days. Results 3,975 subjects were followed 180 days after a first AMI. Women (27.8% of the study population) were older and had more comorbidities. Of the main guideline-recommended drugs, antiplatelets, lipid modifying agents and beta-blockers, were prescribed less often in women. Comedications such as rivaroxaban and calcium channel blockers were more likely to be prescribed in women. The proportion of subjects initiating treatment was similar in both genders. Overall, age and morbidity burden were the main contributors to differences in the prescribing patterns. Living in an urban area seemed to be a protective or mitigating factor. There were controversial results regarding socioeconomic level. Conclusion In our study population, women are older, have greater comorbidities and lower socioeconomic status. Despite this, gender inequalities in the prescribing patterns after a first AMI remains, as women appear to experience less therapeutic effort. It is crucial to analyse them from an intersectional perspective, considering the influence of multiple axes of inequality on health, in order to develop gender-sensitive strategies with a multidisciplinary approach.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Prediction of cardiovascular risk using machine-learning methods. Sex-specific differences

  • Castel-Feced, Sara
  • Aguilar-Palacio, Isabel
  • Malo, Sara
  • González-García, Juan
  • Maldonado, Lina
  • Rabanaque-Hernández, María José
Machine learning (ML) algorithms offer some advantages over traditional scoring systems to assess the influence of cardiovascular risk factors (CVRFs) on the risk of major cardiovascular event (MACE), and could be useful in clinical practice. These algorithms can also be trained using a growing body of real world data (RWD). The aim of the study was to evaluate the MACE risk applying the XGBoost and Random Forest ML algorithms to RWD, stratifying the study population by sex, comparing the outcomes of these two algorithms.MethodsThe follow-up period of the study was from 2018 to 2020. For each algorithm, 3 models were generated, including age and different combinations of three groups of variables: blood test and blood pressure measurements; CVRFs; and medication adherence.ResultsIn this study, 52,393 subjects were included, of whom 581 suffered a MACE. The incidence of MACE was 1% in women and 1.3% in men. The most prevalent CVRF was hypertension, followed by hypercholesterolaemia in both sexes. Adherence to treatment was highest for antihypertensives and lowest for antidiabetics. In all models age was the greatest relative contributor to the risk of MACE, followed by adherence to antidiabetics. Adherence to treatment proved to be an important variable in the risk of having a MACE. Moreover, similar performance was found for RF and XGBoost algorithms.ConclusionThese findings support the use of ML to assess cardiovascular risk and guide personalized prevention strategies in primary care settings.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Factors associated with prescription of modern antidiabetics in newly diagnosed patients with type 2 diabetes. a real-world data study in a Spanish region

  • Bengoa-Urrengoechea, Irantzu
  • Aguilar-Palacio, Isabel
  • Rabanaque, María José
  • Lallana, María Jesús
  • Gamba Cabezas, Adriana
  • Malo, Sara
AimTo describe the patterns of first prescription of antidiabetic drugs (AD) in patients with type 2 diabetes (T2D) and analyze the factors associated with the prescription of a modern one.MethodsObservational longitudinal study conducted in the CArdiovascular Risk factors for HEalth Services research (CARhES) cohort. Individuals older than 15, resident in Aragón (Spain), diagnosed with T2D during 2018–2022 were selected and followed-up until 31st December 2022. Secondary use of data from the health system provided sociodemographic, clinical and pharmacological prescription information. We also considered additional variables by Basic Healthcare Area (BHA) of residence. AD were classified into “classical” and “modern” and their differences were described and compared. A multilevel methodology stratified by sex was developed, considering individual characteristics and characteristics of the BHA of residence, to analyze the factors associated to a modern AD.ResultsOur population-based cohort of 22,892 patients were mostly male, native, low-income and living in non-depopulated BHA. People who were younger, with heart failure, ischemic heart disease, chronic renal failure, obesity, with a previous major adverse cardiovascular event, higher socioeconomic level or lived in less deprived and more depopulated areas were more likely to get a modern AD prescription.ConclusionOur analyses showed that prescribing practices vary according to a range of sociodemographic, clinical and geographical characteristics. Knowledge of these factors is essential for implementing and improving equitable and person-centered approaches.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

When gender matters: inequalities in health services utilization and risk factors monitoring after acute myocardial infarction

  • López-Ferreruela, Irene
  • Gimeno-Miguel, Antonio
  • Laguna-Berna, Clara
  • Malo, Sara
  • Castel-Feced, Sara
  • Rabanaque, María José
  • Aguilar-Palacio, Isabel
Introduction: Secondary prevention after an acute myocardial infarction (AMI) has the objective of improving quality of life, minimizing recurrence, and reducing morbidity and mortality. Despite European guidelines highlighting the importance of cardiovascular risk factor (CVRF) management and optimal healthcare utilization, inequalities persist, particularly between genders. This study aims to identify and analyze gender inequalities in healthcare utilization and CVRF monitoring during the first year after AMI using real-world data (RWD). Methods: An analytical study was conducted within the CARhES (CArdiovascular Risk factors for Health Services research) cohort in Aragon, Spain. The study population included 3,464 subjects who survived a first AMI and were followed for one full year after the event. Sociodemographic, anthropometric, clinical data, healthcare utilization, CVRF monitoring and pharmacological prescriptions, were extracted from the Aragon Health Service. Statistical analyses included chi-squared tests, Student's t-tests, and logistic regression, with Blinder-Oaxaca decomposition applied to explore possible explanatory factors for gender differences. Results: Women represented 28.3% of the study population. Compared with men, they were older and had a higher morbidity burden. Primary care utilization was similar between genders; however, women had fewer cardiology visits (p < 0.001) and were less likely to achieve risk factor monitoring goals. Differences were also observed in pharmacological treatment, with women being less likely to receive beta-blockers, lipid modifying agents, and antiplatelet agents (p < 0.001). Several of these inequalities persisted after controlling for age. The Oaxaca decomposition showed that age and morbidity burden were the main contributors to gender disparities. In addition, socioeconomic status and place of residence played a role in health services utilization differences. Conclusions: Gender inequalities are still present in post-AMI care and CVRF management, with women being more likely to receive less adequate treatment and management. Addressing these inequalities is crucial to ensuring equitable care and improving health outcomes for women.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Prevención primaria en personas mayores: diferencias por sexo en la persistencia al tratamiento con estatinas y el control del colesterol

  • Malo, Sara
  • Rabanaque, María José
  • Gamba, Adriana
  • Vinuesa-Hernando, José Manuel
  • Moreno-Juste, Aida
  • Lallana, María Jesús
  • Cebollada, Jesús
  • Aguilar-Palacio, Isabel
Introduction and objectives: This study aimed to analyze sex differences in statin persistence and associated factors among individuals aged 70 years and older in Spain who initiated statin therapy for primary prevention of cardiovascular disease. Additionally, it assessed the role of sex in low-density lipoprotein cholesterol (LDL-C) control based on the intensity of statin therapy used. Methods: This was an observational longitudinal study conducted within the CARhES (Cardiovascular risk factors for health services research) cohort. Individuals aged ≥ 70 years who initiated statin therapy for primary prevention of cardiovascular disease between 2018 and 2020 were included. Two-year statin persistence was assessed by sex. Considering major cardiovascular events and death as competing risks, the risk of statin discontinuation and its associated factors were estimated using cumulative incidence functions and Fine and Gray analysis. The proportion of men and women achieving LDL-C target levels was also calculated. Results: A total of 4936 older adults (61.7% women) were included. Compared with men, women had higher mean LDL-C levels prior to statin initiation, a greater pharmacological burden, were less likely to receive high-intensity statins, and demonstrated lower persistence. No variables were statistically associated with discontinuation among women. In men, the adjusted HR for discontinuation was 1.03 (95%CI: 1.00-1.06) per 10 mg/dL increase in baseline LDL-C level. Among persistent statin users, women were less likely than men to achieve LDL-C targets, particularly when treated with low- to moderate-intensity statins. Conclusions: Significant sex differences exist in statin persistence, associated factors, and achievement of LDL-C targets among older adults. These findings highlight the importance of considering sex-specific factors when evaluating the appropriateness of statin use in this population. Introducción y objetivos: El objetivo de este estudio fue analizar las diferencias por sexo en la persistencia al tratamiento con estatinas y los factores asociados en una población española mayor de 70 años que inició tratamiento con estatinas para la prevención primaria de la enfermedad cardiovascular. Además, se evaluó el papel del sexo en el control del colesterol unido a lipoproteínas de baja densidad (cLDL) en función de la intensidad del tratamiento con estatinas. Métodos: Estudio longitudinal observacional realizado en la cohorte CARhES (Cardiovascular risk factors for health services research) que incluyó a personas ≥ 70 años que iniciaron tratamiento con estatinas para la prevención primaria de enfermedades cardiovasculares entre 2018 y 2020. Se evaluó la persistencia al tratamiento con estatinas 2 años después en función del sexo. Se consideraron riesgos competitivos los eventos cardiovasculares mayores y la muerte, y se estimó el riesgo de interrumpir el tratamiento y sus factores asociados mediante funciones de incidencia acumulada y análisis de Fine y Gray. También se calculó la proporción de mujeres y varones que alcanzaron los niveles de cLDL recomendados. Resultados: Se incluyó un total de 4.936 personas mayores (61,7% mujeres). En comparación con los varones, las mujeres presentaron valores medios de cLDL más elevados antes de iniciar el tratamiento con estatinas, mayor carga farmacológica, menor probabilidad de recibir estatinas de alta intensidad y menor persistencia al tratamiento, sin variables asociadas a la interrupción. En los varones, la HR ajustada de interrupción del tratamiento fue de 1,03 (IC95%, 1,00-1,06) por cada incremento de 10 mg/dl en el cLDL. Entre los pacientes que seguían en tratamiento con estatinas, las mujeres tuvieron menos probabilidad que los varones de alcanzar los objetivos de cLDL, en particular si recibían tratamiento con estatinas de intensidad baja-moderada. Conclusiones: Existen diferencias significativas en función del sexo en la persistencia al tratamiento con estatinas, los factores asociados y el logro de los objetivos de cLDL entre las personas mayores. Estos hallazgos resaltan la importancia de considerar factores específicos de cada sexo el evaluar la idoneidad del uso de estatinas en esta población.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Dementia Prevalence in the CARhES Cohort: Importance of Socioeconomic Level

  • Lobo, Elena
  • Malo, Sara
  • Aguilar-Palacio, Isabel
  • Castel-Feced, Sara
  • Maldonado, Lina
  • De la Cámara, Concepción
  • Rabanaque, María José
Objectives: Dementia preventive strategies might benefit from a comprehensive approach that considers the interplay of biological and social factors. The aim of this study was to examine the prevalence of dementia by sex and age in a cohort of individuals with cardiovascular risk factors, and to assess how sociodemographic and clinical factors are associated with this disease. Methods: Cross-sectional study was conducted on ≥55-year-old individuals from the CARhES (CArdiovascular Risk factors for HEalth Services research) Spanish cohort. Real-world data on sociodemographic, clinical, and drug information was obtained. Dementia cases were identified by diagnoses and pharmacological treatment. Age- and sex-stratified logistic regression models and sex-stratified CTree analyses were used. Results: The prevalence of dementia among the 323,973 individuals in the cohort was 5.2%, 3.4% in men and 6.6% in women, and it increased with age. In both sex groups, stroke and depression were associated with a higher prevalence of dementia for all the age groups, while sex differences were found in the association of the rest of the sociodemographic and clinical variables with dementia. Being older and with lower socioeconomic status were the most predictive factors of dementia prevalence. Stroke was a stronger indicator in men than in women, while hypertension was nearly twice as significant in women. Conclusions: The prevalence of dementia in people with cardiovascular risk factors was 5.2%, similar to that of the general population. Besides age, having a lower socioeconomic level was the most important indicator of dementia, which may justify more resources and care for these populations.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Cardiovascular risk factors in immigrants: an intersectional real world data approach to understand health inequalities

  • Collazo, Yuleydy
  • Gamba, Adriana
  • Malo, Sara
  • Rabanaque, MJ
  • Carela, Francisco Javier
  • Aguilar-Palacio, Isabel
Cardiovascular risk factors (CVRFs) are shaped by social determinants of health. Lower CVRFs frequency in immigrants, as reported in the literature, may oversimplify a group affected by multiple and intersecting social inequities. Using the framework of intersectionality, we aim to analyse the prevalence of CVRFs using Real-World Data (RWD), in immigrants to better understand how overlapping social identities shape health outcomes. Methods. A cross-sectional observational study was conducted in the immigrant population of the CARhES cohort (45,861) a population cohort of RWD of CVRFs’ patients. In order to characterise the most privileged and oppressed immigrant groups, we considered the impact of country of origin, age group, gender, income level and place of residence on the prevalence of CVRFs. Logistic regression models were used to estimate the effect of socioeconomic characteristics on the presence of three CVRFs. To explore intersectionality, logistic regression models with interactions assessed how sociodemographic variables jointly influenced the presence of three CVRFs. Coefficients were tested for significance using the Wald test, and odds ratios (ORs) were calculated with their 95% confidence intervals (CI). Results. The prevalence of CVRFs was higher in immigrant men, living in urban areas, and increased with aging and low income. The strongest association between socioeconomic variables and the presence of three CVRFs was found in people 65–79 years and among Europeans. This association was independent of their time in the country. Intersectional strata with more CVRFs included individuals aged 65–79 in urban areas, Latin American and Caribbean men and African women. Intersectional analyses showed that African immigrants from urban areas had a higher probability of having the three CVRFs (OR: 1.66, CI = 1.30–2.11), as did African women (OR: 1.40, CI = 1.15–1.69). Females in the most oppressed axes of inequality showed a higher frequency of CVRFs than males. Conclusions. Intersectional approach reveals that the most disadvantaged groups regarding CVRFs include older Latin American and Caribbean men and African women in urban areas. Women facing multiple layers of social oppression are particularly at risk. This RWD-based approach enables the identification of at-risk groups and supports the design of equitable, data-driven health interventions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Primary prevention in older adults: sex differences in statin persistence and cholesterol control

  • Malo, Sara
  • Rabanaque, María José
  • Gamba, Adriana
  • Vinuesa-Hernando, José Manuel
  • Moreno-Juste, Aida
  • Lallana, María Jesús
  • Cebollada, Jesús
  • Aguilar-Palacio, Isabel
Introduction and objectives: This study aimed to analyze sex differences in statin persistence and associated factors among individuals aged 70 years and older in Spain who initiated statin therapy for primary prevention of cardiovascular disease. Additionally, it assessed the role of sex in low-density lipoprotein cholesterol (LDL-C) control based on the intensity of statin therapy used. Methods: This was an observational longitudinal study conducted within the CARhES (Cardiovascular risk factors for health services research) cohort. Individuals aged ≥ 70 years who initiated statin therapy for primary prevention of cardiovascular disease between 2018 and 2020 were included. Two-year statin persistence was assessed by sex. Considering major cardiovascular events and death as competing risks, the risk of statin discontinuation and its associated factors were estimated using cumulative incidence functions and Fine and Gray analysis. The proportion of men and women achieving LDL-C target levels was also calculated. Results: A total of 4936 older adults (61.7% women) were included. Compared with men, women had higher mean LDL-C levels prior to statin initiation, a greater pharmacological burden, were less likely to receive high-intensity statins, and demonstrated lower persistence. No variables were statistically associated with discontinuation among women. In men, the adjusted HR for discontinuation was 1.03 (95%CI: 1.00-1.06) per 10 mg/dL increase in baseline LDL-C level. Among persistent statin users, women were less likely than men to achieve LDL-C targets, particularly when treated with low to moderate-intensity statins. Conclusions: Significant sex differences exist in statin persistence, associated factors, and achievement of LDL-C targets among older adults. These findings highlight the importance of considering sex-specific factors when evaluating the appropriateness of statin use in this population. Introducción y objetivos: El objetivo de este estudio fue analizar las diferencias por sexo en la persistencia al tratamiento con estatinas y los factores asociados en una población española mayor de 70 años que inició tratamiento con estatinas para la prevención primaria de la enfermedad cardiovascular. Además, se evaluó el papel del sexo en el control del colesterol unido a lipoproteínas de baja densidad (cLDL) en función de la intensidad del tratamiento con estatinas. Métodos: Estudio longitudinal observacional realizado en la cohorte CARhES (Cardiovascular risk factors for health services research) que incluyóa personas ≥ 70 años que iniciaron tratamiento con estatinas para la prevención primaria de enfermedades cardiovasculares entre 2018 y 2020. Se evaluó la persistencia al tratamiento con estatinas 2 años después en función del sexo. Se consideraron riesgos competitivos los eventos cardiovasculares mayores y la muerte, y se estimó el riesgo de interrumpir el tratamiento y sus factores asociados mediante funciones de incidencia acumulada y análisis de Fine y Gray. También se calculó la proporción de mujeres y varones que alcanzaron los niveles de cLDL recomendados. Resultados: Se incluyó un total de 4.936 personas mayores (61,7% mujeres). En comparación con los varones, las mujeres presentaron valores medios de cLDL más elevados antes de iniciar el tratamiento con estatinas, mayor carga farmacológica, menor probabilidad de recibir estatinas de alta intensidad y menor persistencia al tratamiento, sin variables asociadas a la interrupción. En los varones, la HR ajustada de interrupción del tratamiento fue de 1,03 (IC95%, 1,00-1,06) por cada incremento de 10 mg/dl en el cLDL. Entre los pacientes que seguían en tratamiento con estatinas, las mujeres tuvieron menos probabilidad que los varones de alcanzar los objetivos de cLDL, en particular si recibían tratamiento con estatinas de intensidad baja-moderada. Conclusiones: Existen diferencias significativas en función del sexo en la persistencia al tratamiento con estatinas, los factores asociados y el logro de los objetivos de cLDL entre las personas mayores. Estos hallazgos resaltan la importancia de considerar factores específicos de cada sexo el evaluar la idoneidad del uso de estatinas en esta población.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Care Pathways After Acute Myocardial Infarction: A Gender-Based Perspective

  • López-Ferreruela, Irene
  • Maldonado, Lina
  • Malo, Sara
  • Rabanaque, María José
  • Aguilar-Palacio, Isabel
Background/Objectives: Secondary prevention after a first acute myocardial infarction (AMI) is crucial to reduce complications and improve long-term outcomes. Persistent gender inequalities in cardiovascular care suggest differences in post-AMI healthcare pathways between men and women. Understanding these trajectories could guide post-discharge clinical management, secondary prevention, and follow-up after acute myocardial infarction. This study aimed to describe healthcare pathways following a first AMI and explore gender inequalities within these trajectories. Methods: We conducted an observational, population-based study using real-world data (RWD) from the CARhES cohort. A total of 4298 individuals discharged alive after a first AMI between 2017 and 2022 were included. Healthcare trajectories during the 90 days following discharge were reconstructed across primary and specialised care, emergency services, and hospital admissions, and stratified by sex and the occurrence of clinical outcomes. Results: Post-AMI care pathways were highly heterogeneous. Although general practitioners often served as the first point of contact, most trajectories began in emergency departments. Patients with clinical outcomes showed higher healthcare utilisation. Women accessed primary care more frequently, whereas men showed greater use of specialised services and higher readmission rates, patterns that may reflect differences in follow-up strategies and clinical management during the early post-discharge period. Despite this variability, overall trajectories showed no significant sex-based differences. Conclusions: Post-AMI care pathways are complex and variable, with gender differences in patterns of service use. Women more often accessed scheduled care, while men relied more on emergency services. These findings highlight the need for gender-sensitive post-discharge follow-up to guide clinicians in secondary prevention strategies for AMI.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Dynamics of healthcare inequalities in type 2 diabetes mellitus across the COVID-19 pandemic: a real-world population-based study

  • Aguilar-Palacio, Isabel
  • Rabanaque, M José
  • Gamba, Adriana
  • Bengoa-Urrengoechea, Irantzu
  • López-Ferreruela, Irene
  • Castel-Feced, Sara
  • Malo, Sara
Background healthcare inequalities have been widely documented, yet the COVID-19 pandemic may have altered their magnitude and direction. This study aimed to analyse the dynamics of healthcare inequalities in patients with type 2 diabetes mellitus (T2DM) before and after the pandemic using a real-world data approach. Methods we conducted a real-world observational study including T2DM patients aged ≥ 45 from the CARhES cohort, a population-based dataset integrating clinical and administrative information from Aragón (Spain), between 2017 and 2022. Healthcare utilisation was assessed at two levels: Primary Care and specialist care. Socioeconomic, clinical, and healthcare variables were retrieved from electronic health records. We described healthcare utilisation patterns and trends across the study period and estimated adjusted prevalence ratios (PRs) for inequality axes (age, gender, migrant status, socioeconomic level, and rurality) using Poisson regression models at three time points (2017, 2020, 2022), adjusting for multimorbidity. Results A total of 86,407 T2DM patients were included. Almost all patients consulted a general practitioner (GP) each year and increased over time, while specialist consultations declined during the pandemic and had not recovered by 2022. Socioeconomic inequalities persisted or widened across most axes. After the pandemic, patients aged ≥ 80 were less likely to visit GP than younger patients, reversing pre-pandemic trends. Women continued to show higher GP use than men but fewer consulted with specialist, although the magnitude of the observed difference was small. Immigrants’ access to specialists decreased relative to natives in 2022. active people with low socioeconomic status showed the lowest specialist consultations, while mutualists had the highest during the pandemic. Rural residents maintained greater reliance on Primary Care but fewer specialist visits post-pandemic. The explanatory power of socioeconomic variables declined in GP models, whereas multimorbidity gained influence during and after COVID-19. Conclusions Healthcare inequalities among T2DM patients persisted and some patterns shifted after 2020. Although GP utilisation increased, nursing and specialist follow-up did not recover to pre-pandemic levels. These patterns underscore the need for targeted interventions to optimise care for older adults, women, migrants, rural residents, and low-income populations, with a focus on promoting digital inclusion and developing tailored healthcare pathways to advance health equity.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Exploring the Impact of the COVID-19 Pandemic on Patients with Type 2 Diabetes and Primary Care Utilisation: A Scoping Review

  • Bengoa-Urrengoechea, Irantzu
  • Malo, Sara
  • Rabanaque, María José
  • Sánchez-Calavera, María Antonia
  • Aguilar-Palacio, Isabel
Background: During the coronavirus disease 2019 (COVID-19) pandemic, changes in healthcare organisation may have affected the management of patients with chronic conditions, such as those with type 2 diabetes (T2D), who require close monitoring. Although there are studies that have analysed the access and management of patients with T2D in primary care (PC) during the pandemic, there is no synthesis of the results that inform us about the care provided and their effect. The aim of this study is to summarise the existing evidence on the care provided in PC settings to patients with T2D during the COVID-19 pandemic, as well as their follow-up care and outcomes, in order to understand the impact of the pandemic on their management. Methods: A scoping review was conducted according to the approach described by Arksey and O’Malley. Structured search strategies were developed for each of the selected databases (PubMed, EMBASE and Web of Science). We included articles published in English and Spanish up to 24 March 2026 on access to care for patients with T2D in PC during the pandemic. Two independent reviewers screened titles and abstracts to select studies related to the population, intervention, and outcomes of interest. In cases of disagreement, a third reviewer resolved the discrepancy. One of the reviewers extracted data and summarised them. Results: After duplicate removal, 535 records were identified, with 116 articles screened in full text and 26 included. Most studies were conducted in Europe and North America using retrospective designs and electronic health records. During the pandemic period, face-to-face visits and routine screenings generally declined, while telemedicine expanded and may have partially mitigated disruptions in patient contact, although inequalities in access were reported. Disease monitoring and complication screening also declined in several settings. Clinical outcomes such as HbA1c and blood pressure (BP) showed heterogeneous trends, with some studies reporting deterioration and others reporting stability. Some studies also highlighted increased adverse events and greater attention to mental health during care. Conclusions: Although telemedicine helped maintain patient follow-up, it could not fully replace face-to-face assessments and was implemented alongside some gaps in clinical monitoring, patient safety, and health equity. These findings underscore the need to maintain structured chronic disease management and to develop safe and inclusive telehealth models.